Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU

Clinical trial NCT00838435 · COMPLETED

Trial details

NCT number: NCT00838435
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Phenylketonuria

Start date: 2009-02-01
Primary completion: 2018-09-14
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.